As per MRFR analysis, the US Animal Model Market Size was estimated at 726.66 (USD Million) in 2023. The US Animal Model Market Industry is expected to grow from 778.4(USD Million) in 2024 to 1,487.2 (USD Million) by 2035. The US Animal Model Market CAGR (growth rate) is expected to be around 6.062% during the forecast period (2025 - 2035).
The US Animal Model Market is currently shaped by several significant trends that reflect the evolving needs of research and development. One of the key market drivers is the rising demand for advanced therapeutic solutions, particularly in areas such as oncology, immunology, and neurology. The increasing complexity of human diseases necessitates the use of animal models to gain a deeper understanding of disease mechanisms and test potential treatments effectively.
Regulatory bodies, including the Food and Drug Administration (FDA), are emphasizing the importance of animal models in the drug development process, further driving the demand in this market. Opportunities to be captured within the US Animal Model Market include the growing interest in personalized medicine and targeted therapies. Companies are focusing on developing genetically modified animal models that can simulate specific human diseases more accurately. This trend not only enhances the relevance of preclinical studies but also leads to improved success rates in clinical trials.
Collaborations between academic institutions and pharmaceutical companies are expected to foster innovation, paving the way for new model developments that can address specific research challenges. Recent times have also seen a shift towards the ethical use of animal models, influenced by public sentiment and regulatory changes. There is a greater emphasis on the 3Rs principle—Replacement, Reduction, and Refinement—advocating for humane practices in research. This shift is prompting researchers to seek alternatives and minimizing the number of animals used while enhancing their welfare.
Moreover, advancements in technology, such as 3D bioprinting and artificial intelligence, are increasingly integrated into the traditional animal research framework, creating exciting avenues for future exploration in human health. Overall, the landscape is dynamic and evolving, reflecting a blend of scientific advancement and ethical considerations in the US.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The rise in chronic diseases such as cancer, diabetes, and cardiovascular diseases in the United States significantly drives the US Animal Model Market Industry. According to the Centers for Disease Control and Prevention (CDC), approximately 6 in 10 Americans have a chronic disease, with cancer rates accounting for about 1.8 million new cases annually.
This alarming statistic highlights the urgent need for research to develop effective treatments and therapies, driving demand for animal models in Research and Development (R&D) processes. Organizations like the American Cancer Society and the National Institutes of Health have been pivotal in backing extensive research, ultimately leading to enhanced funding and resources directed toward studies involving animal models. Consequently, the heightened focus on chronic diseases results in an expanded application of animal models in clinical research settings, fostering growth in the US Animal Model Market Industry.
Innovations in biotechnology are rapidly evolving, contributing significantly to the growth of the US Animal Model Market Industry. The National Institutes of Health reports that biotechnology firms have seen substantial investments, surpassing $74 billion, catalyzing advancements related to genetic engineering and tailored therapies.
This surge in budget allocations towards biotechnology-based research creates a robust demand for animal models, essential for understanding biological processes and testing new drug candidates. As companies such as Amgen and Genentech lead in biopharmaceutical innovation, the focus on utilizing animal models for preclinical testing enhances the industry's growth trajectory in the U.S.
The United States remains a leading hub for pharmaceutical research and development, with expenditures exceeding $90 billion annually. This significant investment trend positively influences the US Animal Model Market Industry as pharmaceutical companies increasingly rely on animal models to ensure drug safety and efficacy.
The Biophysical Society highlights that approximately 75% of new drug candidates undergo animal testing before they reach clinical trials. Moreover, major pharmaceutical companies like Pfizer and Johnson & Johnson leverage animal models to advance their Research and Development processes, thereby propelling market growth. The continuous push for innovation in drug development further stimulates the need for diverse animal models, ultimately benefiting the market.
The regulatory landscape in the United States supports the use of animal models in research, which is vital for the US Animal Model Market Industry. Agencies such as the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) mandate preclinical testing on animal models to ensure the safety of drugs and chemicals before they reach humans.
This regulatory requirement for comprehensive testing provides a solid framework that encourages the use of animal models in research and product development. Additionally, the National Research Council's emphasis on the 3Rs principle (Replacement, Reduction, Refinement) facilitates ethical frameworks coupled with significant investments in animal welfare, thus promoting animal models' acceptance and usage in advancing biomedical research. Such support from regulatory bodies creates a positive outlook for the market's growth.
The US Animal Model Market encompasses various animal types that are instrumental for research, drug development, and various scientific investigations. Among these, animals such as pigs, cats, and mice play a crucial role due to their unique biological traits and similarities to human physiology.
The increasing complexity of disease modeling and the support from regulatory bodies in the US further underline the necessity of these animal types in the scientific community. Trends in biomedicine, including personalized medicine and advanced therapeutic modalities, emphasize the reliance on these animals for the exploration and validation of innovative treatment options. Growth drivers in the US market revolve around the rising funding for research initiatives and the growing synergy between academic institutions and industry that aim to translate scientific discoveries into real-world applications. Challenges related to ethical considerations and increasing regulations surrounding animal welfare persist, but they simultaneously drive the development of alternative methods and technologies that could enhance research outcomes. Overall, the various animal types within the US Animal Model Market are pivotal in supporting research and development initiatives, impacting both human health and the advancement of veterinary practices.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Technology segment of the US Animal Model Market plays a crucial role in enhancing research capabilities and advancing scientific discoveries. CRISPR technology has gained significant traction due to its precise genome-editing capabilities, allowing for efficient genetic manipulation that is vital for research in various fields, including genetics and disease modeling.
The growth of these technologies is driven by increasing investments in Research and Development initiatives, demand for personalized medicine, and a rising focus on ethical research practices. However, the market also faces challenges such as regulatory hurdles and ethical considerations surrounding animal testing, which can impact the adoption of these advanced technologies. Overall, the dynamic landscape within this technology segment supports innovation and contributes significantly to the US Animal Model Market statistics and data trends.
The US Animal Model Market is experiencing notable growth, driven by applications in Research and Development, Production, and Quality Control. The importance of these applications cannot be understated, as they support various industries, including pharmaceuticals and biotechnology, in developing innovative therapies and testing products.
As regulatory standards evolve and the demand for more sophisticated models increases, the segmentation within the US Animal Model Market is expected to adapt accordingly. Furthermore, the ongoing emphasis on ethical considerations in animal research will likely influence how these applications are implemented, promoting a more humane approach while maintaining scientific rigor. Overall, the Application segment in the US Animal Model Market represents a vital foundation for advancement in healthcare and science.
The End-User segment of the US Animal Model Market encompasses various key players including Research Institutes, Educational Institutes, Pharmaceutical Companies, and Contract Research Organizations. Research Institutes are essential for conducting advanced studies and developing new therapies, thereby driving significant contributions to overall market dynamics.
The collaborative efforts among these various entities enhance innovation and accelerate market development, driven by growing R&D investments within the US which further solidify the significance of these End-Users in the overall landscape of the US Animal Model Market. This segment reflects the ongoing trends in biomedical research and emphasizes the critical role of animal models in achieving groundbreaking medical advancements.
The US Animal Model Market is a vital segment within the broader life sciences industry, focusing on the development and distribution of animal models used for research and development in pharmaceuticals, biotechnology, and academic institutions. Competitive dynamics within this market are characterized by a mix of established players and emerging firms, each striving to enhance their offerings through innovative breeding, genetics, and customization of animal models to meet specific research requirements.
The industry's growth is significantly influenced by advancements in genetic engineering and an increasing demand for reliable preclinical models for drug testing and disease studies. Companies are continuously pursuing strategies such as partnerships, collaborations, and mergers to expand their market presence and enhance their product portfolios, which contributes to a dynamic and competitive landscape.
Taconic Biosciences is a key player in the US Animal Model Market, known for its extensive range of genetically engineered models that cater to various research needs. The company boasts significant strengths in its ability to produce custom models, which allows researchers to have tailored solutions for their specific projects.
Taconic's robust infrastructure and high-quality animal husbandry practices ensure that their models are reliable for preclinical research. The company has established a strong foothold in the market by leveraging its extensive experience in the field and maintaining rigorous quality control measures. Additionally, Taconic's commitment to innovation and customer service has enhanced its reputation as a trusted provider, enabling it to forge long-lasting relationships with academic and industry partners across the United States.
SABC is another prominent player within the US Animal Model Market, offering a wide array of animal models for research purposes. The company focuses on providing genetically modified organisms, which are crucial in various research sectors, including cancer, metabolic disorders, and immunology.
SABC's strengths lie in its comprehensive product portfolio alongside advanced research capabilities that facilitate custom breeding and development of unique animal models. The company has also expanded its market presence through strategic mergers and acquisitions, enhancing its research capabilities and geographic reach. With ongoing investments in technology and infrastructure, SABC is well-positioned to meet the evolving needs of researchers and continues to solidify its role as a leader in the US animal model market. Its focus on high-quality service and innovative solutions distinguishes SABC from competitors, making it a valuable partner in the research community.
The US Animal Model Market has recently witnessed several significant developments. In September 2023, Charles River Laboratories announced the acquisition of the global mouse model company, expanding its portfolio to enhance its research capabilities in preclinical models. This acquisition aligns with the increasing demand for advanced models in drug discovery.
In October 2023, Taconic Biosciences launched a new genetically engineered mouse model to support Research and Development in cancer therapy, catering to the growing needs of the biomedical research community. Additionally, Eurofins Scientific has been investing in expanding its animal model services, emphasizing improved welfare standards and compliance with regulatory requirements. The market valuation for companies such as Jackson Laboratory and Envigo has seen substantial growth, attributed to the escalating focus on precision medicine and personalized healthcare.
Furthermore, in April 2022, Bolder BioTechnology secured a new funding round to advance its capabilities in animal model development, signaling a positive investment climate. Overall, the US Animal Model Market is experiencing a surge in technological advancements, strategic acquisitions, and a heightened emphasis on ethical practices, all contributing to its dynamic growth and evolution.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 726.66(USD Million) |
| MARKET SIZE 2024 | 778.4(USD Million) |
| MARKET SIZE 2035 | 1487.2(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.062% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Taconic Biosciences, SABC, Maryland Medical Research Institute, In Vivo Biosystems, Bolder BioTechnology, Jackson Laboratory, Harlan Laboratories, Feldan Therapeutics, Harvard University, Eurofins Scientific, Envigo, Charles River Laboratories, Duke University |
| SEGMENTS COVERED | Animal Type, Technology, Application, End-User |
| KEY MARKET OPPORTUNITIES | Increasing demand for personalized medicine, Growth in biopharmaceutical research, Advancements in genetic engineering models, Rising prevalence of chronic diseases, Expansion of contract research organizations |
| KEY MARKET DYNAMICS | Increasing R&D expenditure, Rising demand for personalized medicine, Regulatory changes for animal testing, Technological advancements in models, Growing prevalence of chronic diseases |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Animal Model Market is expected to be valued at 778.4 million USD in 2024.
In 2035, the overall market value is projected to be 1487.2 million USD.
The expected CAGR for the US Animal Model Market from 2025 to 2035 is 6.062%.
In 2024, Mice hold the largest market value at 328.4 million USD in the US Animal Model Market.
The projected market value for Pigs in the US Animal Model Market by 2035 is 480.0 million USD.
Major players in the US Animal Model Market include Taconic Biosciences, Charles River Laboratories, and Jackson Laboratory.
The market value for Cats in the US Animal Model Market is estimated to be 200.0 million USD in 2024.
There are numerous growth opportunities in the US Animal Model Market driven by advancements in biotechnology and research applications.
The market growth rate in the US Animal Model Market will vary, with Pigs and Mice expected to show significant increases by 2035.
Challenges for the US Animal Model Market include regulatory hurdles and ethical considerations surrounding animal testing.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
